M. Kamil, Mohammed, et al. “Immunogenicity of the Biosimilar CT-P13 Infliximab or the Original Infliximab in Iraqi Patients With Ankylosing Spondylitis Does Not Correlate With Their Demographic Characteristics”. Journal of the Faculty of Medicine Baghdad, vol. 64, no. 4, Jan. 2023, pp. 261-7, https://doi.org/10.32007/jfacmedbagdad.6441969.